Denmark-based wind turbine manufacturer MHI Vestas Offshore Wind on Wednesday forged cooperation links with several Taiwanese material suppliers in a bid to make inroads into Taiwan’s market and markets in Southeast Asia.
MHI Vestas signed memorandums of understanding (MOUs) with Kaohsiung-based China Steel Machinery Corp (中鋼機械) for cooperation in the manufacture of wind turbine towers; with Tienli Offshore Wind Power Technology Co Ltd (天力離岸風電科技) for the production of wind turbine blades; with Swancor Holding Co Ltd (上緯) for composite materials and fossil resins; and with Formosa Plastics Corp (台塑) for raw materials used in the production of turbine blades.
The collaboration is to enable the firm to assemble wind turbines with materials produced by the Taiwanese companies, MHI Vestas CEO Philippe Kavafyan said during the signing ceremony.
MHI Vestas was attracted by Taiwan’s advanced manufacturing capacity and the government’s keenness to explore and develop renewable energy resources, he said.
The company was founded in 2014 as a joint venture between Mitsubishi Heavy Industries Ltd and Vestas Wind Systems A/S.
It manufactures, installs and operates wind turbines that are used by energy companies to generate power in offshore locations.
On Tuesday, MHI Vestas was chosen by China Steel Corp (中鋼) and Copenhagen Infrastructure Partners as their wind turbine supplier for their wind projects off Taiwan’s west coast.
Describing Taiwan as MHI Vestas’ priority market, Kavafyan said his company is expected to introduce new opportunities to Taiwan in the areas of employment, procurement and manufacturing.
The MOUs represent MHI Vestas’ pledge to put down roots in Taiwan, he said, adding that the company plans to push further into the Southeast Asian market in response to the government’s New Southbound Policy.
After the ceremony, Kavafyan told reporters that MHI Vestas plans to set up its Asia-Pacific headquarters in Taiwan by the second quarter of this year and that it could possibly establish a production line in the nation in about 2022, depending on licensing procedures.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS